The article mentions performing myriad assays as a rate-limiting step in drug discovery. My employer https://www.synthace.com is trying to accelerate this process through software. We’ve created a platform to easily program liquid handling robots to perform complex protocols, and to do so using a Design-of-Experiments[1] approach to investigate multiple factors simultaneously. It’s early days for this approach but we’ve already had pharma customers using it to significantly accelerate their drug discovery process.
[1] https://en.m.wikipedia.org/wiki/Design_of_experiments